In focus
Latest feed
Jim Cramer's Prudent Take: Natera Soars, But Should Investors Hit the Brakes?
Stoke Therapeutics’ Dravet‑Syndrome Gene Therapy Nears the Finish Line
Arcturus Therapeutics' Stock Soars: A Landmark Manufacturing Partnership with Thermo Fisher Scientific
Gain Therapeutics Shares Soar: Unpacking the Preclinical Breakthrough in Parkinson's and Gaucher Disease
Latest headlines
